D 159687

CAS No. 1155877-97-6

D 159687 ( —— )

Catalog No. M20211 CAS No. 1155877-97-6

D159687 is a selective?PDE4D?inhibitorhad a procognitive profile as it improved memory in the novel object recognition test but had no antidepressant or anxiolytic benefit.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 69 In Stock
25MG 147 In Stock
50MG 237 In Stock
100MG 381 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    D 159687
  • Note
    Research use only not for human use.
  • Brief Description
    D159687 is a selective?PDE4D?inhibitorhad a procognitive profile as it improved memory in the novel object recognition test but had no antidepressant or anxiolytic benefit.
  • Description
    D159687 is a selective?PDE4D?inhibitorhad a procognitive profile as it improved memory in the novel object recognition test but had no antidepressant or anxiolytic benefit.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE4D
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1155877-97-6
  • Formula Weight
    366.85
  • Molecular Formula
    C21H19ClN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL?(408.90 mM)
  • SMILES
    COc1ccc(Cc2ccc(NC(N)=O)cc2)cc1-c1cccc(Cl)c1
  • Chemical Name
    [4-[[3-(3-Chlorophenyl)-4-methoxyphenyl]methyl]phenyl]urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang C et al. Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System. Sci Rep. 2017 Jan 5;7:40115.
molnova catalog
related products
  • HT-0712

    HT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3.

  • Cilostazol

    Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.

  • Darutigenol

    Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.